Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study

Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study

Context: Benign Prostatic Hyperplasia (BPH) is a common disease that course with Lower Urinary Tract Symptoms (LUTS), mainly in over 50 years-old men. Commonly indicated drugs such as alpha adrenergic-blockers are life-treatment with some adverse reactions. Center for Drug Research and Development p...

Full description

Bibliographic Details
Main Authors: Magnelis Machado-Leiva, Daise Jiménez-Rodríguez, Tatiana Festary-Casanovas, Deydree C. Silveira-Pacheco, Emilio S. Barroso-de la Cruz, Mariela Suárez-Reyes, Genma Salas-Cruz, Haydee Wong-Arocha, Roberto Fernández-Viera, Ángela D. Tuero-Iglesias, René Delgado-Hernández, Idrian García-García, Calprost Study Group
Format: Article
Language:English
Published: Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) 2016-10-01
Series:Journal of Pharmacy & Pharmacognosy Research
Subjects:
Benign prostatic hyperplasia
Calprost
IPSS
lower urinary tract symptoms
pumpkin seed oil
terazosin
Online Access:http://jppres.com/jppres/pdf/vol4/jppres16.142_4.5.187.pdf

Internet

http://jppres.com/jppres/pdf/vol4/jppres16.142_4.5.187.pdf

Similar Items